Belgium 3D Imaging Market Analysis Report 2022 to 2030

Belgium 3D Imaging Market Analysis

$ 3999

Belgium's 3D imaging market is projected to grow from $xx Bn in 2022 to $xx Bn by 2030, registering a CAGR xx% during the forecast period of 2022-30. The market will be driven by increased healthcare investments, the rising prevalence of chronic illnesses & rising demand for customized treatment. The market is segmented by product, application, end-user & by portability. Some of the major players include GE Healthcare, Siemens Healthineers & Agfa HealthCare

ID: IN10BEDH001 CATEGORY: Digital Health GEOGRAPHY: Belgium AUTHOR: Vidhi Upadhyay

Buy Now

Belgium 3D Imaging Market Executive Summary

Belgium's 3D imaging market is projected to grow from $xx Bn in 2022 to $xx Bn by 2030, registering a CAGR xx% during the forecast period of 2022-30. Belgium's healthcare spending in 2019 was $4,960 (10.7% of GDP), a 3.39% decrease from the previous year but higher than the EU average of 9.9%. Tobacco use, dietary concerns, and excessive alcohol consumption are leading causes of death in Belgium. Overweight and obesity rates have also risen as a result of poor diet and insufficient physical exercise.

Belgium has an advanced healthcare system and is on the front edge of medical technology, making it a perfect site for 3D Imaging applications. 3D Imaging technologies have been utilized in Belgium for various applications such as medical study to better comprehend the human body and its disorders. Researchers may investigate the structure and function of organs and tissues in more detail by constructing 3D models, which can aid in the development of novel treatments and cures. Researchers from the Hôpital Erasme, Université Libre de Bruxelles (Brussels, Belgium), discovered a unique imaging technology to enhance the diagnostic accuracy of Basal Cell Carcinoma (BCC) by 12%, minimizing the need for unwanted biopsy procedures. Other applications such as diagnosis and treatment planning of various medical conditions, aiding surgical navigations to the practitioners to locate the exact location of the tumor to make precise incisions, creating custom dental implants & for training medical students and healthcare practitioners.

Market Dynamics

Market Growth Drivers

The elements and events driving the rise of 3D Imaging in Belgium are numerous and varied. In January 2023, Agfa HealthCare and HeiligHart hospital in Lier, Belgium, have agreed to collaborate on a hospital-wide Cloud-based Enterprise Imaging solution and as this technology becomes more widely used, it is expected to enhance patient outcomes and expand medical expertise in Belgium. Several variables are driving the expansion of 3D Imaging in Belgium, including increased healthcare investments, expanding demand for customized treatment, rising understanding of the benefits of 3D medical imaging, and the rising prevalence of chronic illnesses. These aspects have resulted in the widespread use of 3D Imaging technology in a variety of medical applications.

Market Restraints

By the end of March 2022, the Belgian Ministry of Foreign Affairs website said that the country had provided more than $9.64 Mn in humanitarian relief to a devastated Ukraine via various NGOs. The rising military budget is likely to have an impact on the budget allocations for such high-end Imaging procedures in Belgium. Moreover, Other restraints such as high acquisition and maintenance costs, regulatory hurdles, lengthy approval processes, limited accessibility towards the rural population, shortage of specialized training and expertise requirements, and privacy and data security concerns regarding patient data are expected to pose a hurdle to the growth of Belgium 3D Imaging market.

Competitive Landscape

Key Players

GE Healthcare
Siemens Healthineers
Philips Healthcare
Canon Medical Systems
Fujifilm Holdings Corporation
Hitachi Healthcare
Sectra AB
Agfa HealthCare (BEL)

Notable Deals

In March 2022, Philips extended its network of clinical partners in order to establish a new standard of care for the early detection and treatment of lung cancer. Philips Lung Suite real-time 3D Imaging technology is made available in Belgium, France, Israel, and the United Kingdom.

February 2022, FUJIFILM VisualSonics, a global producer of ultra-high-frequency (UHF) ultrasound imaging systems, collaborated with PIUR IMAGING, the European leader in tomographic ultrasound imaging, to deliver UHF, three-dimensional (3D) ultrasound imaging technology to physicians and researchers. This technical innovation aids clinical research in the evaluation of defects in a variety of applications such as dermatology, neurology, vascular, and MSK.

Healthcare Policies and Regulatory Landscape

The Federal Agency for Medicines and Health Products (FAMHP) is the regulatory authority in Belgium in charge of regulating and monitoring the research, production, and distribution of pharmaceuticals, medical devices, and other healthcare items. This agency is in charge of ensuring the safety and quality of medical devices, including 3D Imaging technologies.

Belgian Health Care Knowledge Centre (KCE) is an independent scientific research organization in Belgium that provides evidence-based recommendations to policymakers and healthcare practitioners.

Reimbursement Scenario

The National Institute for Health and Disability Insurance (INAMI-RIZIV) is in charge of medical service and equipment reimbursement in Belgium, including 3D medical imaging. This agency determines medical service and equipment reimbursement rates and reimburses healthcare professionals that employ 3D Imaging in their practice.

1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Belgium 3D Imaging Market Segmentation

By Product (Revenue, USD Billion):

The 3D Imaging Market is divided majorly into X-ray Imaging Systems, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound & Nuclear Imaging Systems. X-ray Imaging systems have the highest market share in the 3D Imaging market. 3D X- rays are mostly utilized for dental and orthopedic applications. 3D Ultrasound is majorly helpful in tracking the dynamic motion of arteries, and veins and also has applications for various fetal, cardiac, obstetric, and rectal examinations, and many more. The ultrasound segment is predicted to develop substantially over the forecast period, primarily to the advancements in technology in the healthcare industry and the several advantages given by 3D ultrasound imaging over standard ultrasound imaging.

X-ray Imaging Systems
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Ultrasound
Nuclear Imaging systems

By Application (Revenue, USD Billion):

The market for 3D Imaging has applications covering Cardiology, Neurology, Orthopaedics, Gynaecology, Oncology, and other areas of diagnostics as well. Cardiovascular diseases are the leading cause of death globally. The second biggest cause is cancers because of which Oncology holds the highest market share in the 3D Imaging market followed by cardiology as 3D imaging is highly utilized in these two segments for diagnostics and treatments of the same. Neurosurgeons desire three-dimensional (3D) imagery of intracranial tumors, neural structures, skulls, and veins to establish a clear visual image of the surgical field's anatomical orientation prior to surgical intervention aiding better surgical outcomes for patients. Obstetricians employ 3D ultrasound scans to see the gestational sac, pinpoint the location of an ectopic pregnancy, and evaluate for fetal deformities of the face, spine, limbs, and heart. 3D Imaging applications for gynecology are yet in evolving stage and have a great scope for expansion allowing feasible and quick patient care.

Cardiology
Neurology
Orthopedics
Gynecology
Oncology
Others (Urology, etc.)

By End User (Revenue, USD Billion):

Hospitals, Diagnostic Imaging Centers, and other end-user such as private clinics make up the segments of the 3D Imaging Market. The hospitals among these hold the biggest market share due to the increased uptake of cutting-edge medical technology, the expansion of existing 3D Imaging facilities, the rising affordability of 3D Imaging services, the rising prevalence of chronic conditions such as cardiovascular diseases, cancers, respiratory diseases which lead to rising in demand for precise and quick diagnostic and treatment options. Diagnostic Imaging Centers have also been deploying 3D Imaging equipment to improve their standard of care.

Hospitals
Diagnostic Imaging Centers
Other End Users

By Portability (Revenue, USD Billion):

The 3D Imaging market is divided into two segments Stationary & Mobile, considering the portability of the device. Stationary 3D imaging involves equipment that is installed at a particular location and is operated from the same location of installment whereas mobile ones can be relatively smaller in size and hence moved to the patients who are unable to locate the Imaging room. Mobile MRI, Ultrasound, X–ray & CT allow cutting-edge healthcare to be delivered to nearly any location and are yet in the developing stages of expansion.

Stationary
Mobile

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.